Medivir completes initial Phase Ib part of HCC therapy trial

cafead

Administrator
Staff member
  • cafead   Feb 21, 2023 at 10:12: AM
via Medivir has completed the initial dose escalation part (Phase Ib) of its Phase Ib/IIa trial of fostroxacitabine bralpamide (fostrox), along with Lenvima, in hepatocellular carcinoma (HCC).

article source
 

<